Home / Recalls / Viatris Inc / D-0204-2025

D-0204-2025 Class II Terminated

Recalled by Viatris Inc — Canonsburg, PA

Recall Details

Product Type
Drugs
Report Date
January 22, 2025
Initiation Date
December 23, 2024
Termination Date
November 12, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,605/30 count bottles

Product Description

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Distribution Pattern

USA nationwide.

Code Information

Lot# 8182298, Exp 10/31/2025

Other recalls by Viatris Inc

  • D-0203-2025 Class II — Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, (December 23, 2024)
  • D-0127-2025 Class II — Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0119-2025 Class II — Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0124-2025 Class II — Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0128-2025 Class II — Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0123-2025 Class II — Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0121-2025 Class II — Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0125-2025 Class II — Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0126-2025 Class II — Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0122-2025 Class II — Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)